Intangible Assets (Details) - USD ($) |
3 Months Ended | 15 Months Ended | ||||
|---|---|---|---|---|---|---|
Feb. 25, 2024 |
Sep. 19, 2022 |
Aug. 23, 2021 |
Sep. 30, 2025 |
Sep. 30, 2024 |
Sep. 30, 2025 |
|
| Finite-Lived Intangible Assets [Line Items] | ||||||
| Amortization of Intangible Assets | $ 5,000 | $ 5,000 | $ 5,000 | |||
| Stock Purchase Agreement | RubrYc Therapeutics | ||||||
| Finite-Lived Intangible Assets [Line Items] | ||||||
| Investment in RubrYc | $ 7,500,000 | |||||
| Asset Purchase Agreement | RubrYc Therapeutics | ||||||
| Finite-Lived Intangible Assets [Line Items] | ||||||
| Investment in RubrYc | $ 1,342,000 | |||||
| PD-1 Asset Purchase Agreement | Otsuka Pharmaceutical | Intellectual Property | ||||||
| Finite-Lived Intangible Assets [Line Items] | ||||||
| Proceeds from sale of intellectual property | $ 1,000,000 | |||||
| Potential contingent payments related to sale of intellectual property | $ 52,500,000 | |||||
| X | ||||||||||
- Definition Potential amount of contingent payments receivable by the company upon achievement of specified milestones following commercialization. No definition available.
|
| X | ||||||||||
- Definition The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of consideration transferred in asset acquisition. Includes, but is not limited to, cash, liability incurred by acquirer, and equity interest issued by acquirer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The cash inflow from disposal of asset without physical form usually arising from contractual or other legal rights, excluding goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|